ZELMYNDIS

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ZELMYNDIS was filed as Word mark on 02/28/2020 at the World Intellectual Property Organization.

Trademark Details Last update: November 24, 2021

Trademark form Word mark
File reference 1526682
Countries Australia Canada Switzerland China European Community United Kingdom South Korea Norway
Base trademark US No. 88605695, September 5, 2019
Application date February 28, 2020
Expiration date February 28, 2030

Trademark owner

3201 Carnegie Avenue
Cleveland OH 44115
US

Trademark representatives

1621 Euclid Avenue, Floor 19 Cleveland OH 44115 US

goods and services

05 Stem cells for scientific and medical research; stem cells for medical or clinical use; pharmaceutical compositions comprising stem cells; pharmaceutical compositions comprising stem cells for the treatment of neurological, cardiovascular, inflammatory and immune diseases, critical care disorders, conditions and injuries, solid organ transplantation, wound healing and orthopedics

Trademark history

Date Document number Area Entry
September 2, 2021 2021/35 Gaz CA Rejection
August 18, 2021 2021/34 Gaz KR Rejection
April 6, 2021 2021/14 Gaz NO Rejection
March 12, 2021 2021/11 Gaz CH Rejection
January 12, 2021 2021/2 Gaz AU Rejection
November 3, 2020 2020/46 Gaz RAW: Partial Cancellation
September 15, 2020 2020/39 Gaz EM Rejection
August 24, 2020 2020/35 Gaz GB Rejection
August 17, 2020 2020/35 Gaz CN Rejection
February 28, 2020 2020/15 Gaz US Registration

ID: 141526682